Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Lupin bags India Pharma Leader Award at India Pharma 2020 and India Medical Device 2020 ConferenceLupin bags India Pharma Leader Award at India Pharma 2020 and India Medical Device 2020 Conference
    Torrent Pharma gets shareholder nod to raise up to Rs 5,000 croresTorrent Pharma gets shareholder nod to raise up to Rs 5,000 crores
    Pharmacist at Punes reputed hospital arrested for stealing masksPharmacist at Pune's reputed hospital arrested for stealing masks
    USFDA completes inspection of Natcos Kothur formulation facilityUSFDA completes inspection of Natco's Kothur formulation facility
    Coronavirus: 5 medical stores license cancelled for selling masks, sanitisers at inflated ratesCoronavirus: 5 medical stores license cancelled for selling masks, sanitisers at inflated rates
    FDA, FTC Warn Seven Companies Selling Fraudulent Products to Treat COVID-19FDA, FTC Warn Seven Companies Selling Fraudulent Products to Treat COVID-19
    Zydus, XOMA enter into licensing agreement for  IL-2-Based Immuno-Oncology TherapyZydus, XOMA enter into licensing agreement for IL-2-Based Immuno-Oncology Therapy
    CDSCO updates FAQs Drugs & Clinical Trial Rules 2019CDSCO updates FAQs Drugs & Clinical Trial Rules 2019
    USFDA Accepts Biocon, Mylans application for review of   Proposed Biosimilar of BevacizumabUSFDA Accepts Biocon, Mylan's application for review of Proposed Biosimilar of Bevacizumab
    AstraZeneca fails to meet target endpoints in Phase II bladder cancer trialAstraZeneca fails to meet target endpoints in Phase II bladder cancer trial
    Biogen, Sangamo collaborate for gene regulation therapies in neurological ailmentsBiogen, Sangamo collaborate for gene regulation therapies in neurological ailments
    NPPA gives a deadline to manufacturers to submit availability data of 58 APIsNPPA gives a deadline to manufacturers to submit availability data of 58 APIs
    PrevNext

    Popular Stories

    Drug marketers to take onus for quality of drugs, regulatory compliance: Health Ministry Gazette

    Drug marketers to take onus for quality of drugs, regulatory compliance: Health Ministry Gazette

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    MSD India appoints Rehan A Khan as Managing Director

    MSD India appoints Rehan A Khan as Managing Director

    China offers tariff exemptions on US medical equipment amid virus outbreak

    China offers tariff exemptions on US medical equipment amid virus outbreak

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Government to frame new rules on medical devices to draw investments

    Government to frame new rules on medical devices to draw investments

    Radiation Protection absolute necessity for Medical Professionals- Mr Satyaki Banerjee, CEO, Kiran Medical Systems, Trivitron Healthcare

    Radiation Protection absolute necessity for Medical Professionals- Mr Satyaki Banerjee, CEO, Kiran...

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok